首页> 美国卫生研究院文献>Journal of Blood Medicine >Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms
【2h】

Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms

机译:患者的深静脉血栓形成具有中等预测试概率和阴性D-二聚体测试:对诊断算法的综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Modern diagnostic strategies of venous thromboembolism (VTE) have been developed. In this review, the diagnostic algorithms for deep-vein thrombosis (DVT) and their parameters are discussed individually in the context of reporting a case of DVT in a 43-year-old Caucasian female with a moderate pretest probability stratified by Wells’ score and a negative high quality D-dimer test. The patient was on treatment with Xarelto (rivaroxaban), 20 mg PO daily at the time of presentation. The diagnosis was verified through a complete lower limb ultrasound (US). This case highlights the diagnostic challenges and pitfalls of the current algorithms, especially those seen in a subgroup of patients such as patients with cancer, pregnancy, recurrent VTE or are on anticoagulation therapy at the time of presentation. The diagnosis of DVT is less plausible in a patient who is on anticoagulation therapy, but physicians should be aware of such a possibility. Physicians should also know in advance the numerous clinically relevant limitations of D-dimer testing before interpreting the results. Unifying the current diagnostic strategies, modifying the current Wells’ score and using the protocol of a whole-leg compression US instead of the limited US protocol are among the several cautious suggestions that have been proposed based on this review to possibly decrease the incidence of missed DVT.
机译:已经开发出现代静脉血栓栓塞(VTE)的现代诊断策略。在本次审查中,在一个43岁的白种人女性中报告DVT的情况下,单独讨论深静脉血栓形成(DVT)及其参数的诊断算法,其在43岁的白种人女性中具有中度预测概率和井分数负优质D-二聚体测试。患者在介绍时与Xarelto(rivaroxaban)进行治疗,在介绍时每天20毫克。通过完整的下肢超声(US)验证了诊断。这种情况突出了目前算法的诊断挑战和缺陷,特别是在患有癌症,妊娠,复发vTE患者的患者的亚组中看到的挑战和缺陷,或者在呈现时抗凝治疗。 DVT的诊断在患有抗凝治疗的患者身上不合理,但医生应该意识到这种可能性。医生还应该在解释结果之前提前知道D-DIMOR测试的许多临床相关局限性。统一当前的诊断策略,修改当前井的分数并使用整个腿部压缩的协议,而不是有限的美国协议是根据本综述提出的几个谨慎建议,以便可能降低错过的发病率DVT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号